Jane Street’s Cellyan Biotechnology HKPD Stock Holding History

Jane Street’s Portfolio HKPD Stock Details HKPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.7K	Buy	+49,087	New	+$26.9K	﹤0.01%	11226
2025 Q3	–	Sell	-17,026	Closed	-$21.8K	–	12108
2025 Q2	$21.8K	Sell	17,026 -3,664	-18%	-$4.53K	﹤0.01%	9348
2025 Q1	$22.3K	Buy	+20,690	New	+$36.5K	﹤0.01%	9141

Other funds holding HKPD

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street's HKPD Position: Q2 2026 in Review

Jane Street opened a new position in Cellyan Biotechnology (HKPD) in Q2 2026: 49,087 shares worth $18.7K. The stake represents ﹤0.01% of the portfolio and ranks #11226 among its holdings. This is a return to the name: Jane Street previously reported a position in HKPD as recently as Q2 2025.

Jane Street first reported a position in HKPD in Q1 2025 and has held it in 3 quarters since. The position peaked at $22.3K in Q1 2025. 6 funds tracked by Wall St. Rank hold HKPD as of Q2 2026.

Jane Street held 49,087 shares of Cellyan Biotechnology worth $18.7K as of Q2 2026.
Cellyan Biotechnology was a new Jane Street position in Q2 2026.
Cellyan Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11226 holding.
Jane Street first reported a position in Cellyan Biotechnology in Q1 2025 and has held it in 3 quarters since.
Jane Street's Cellyan Biotechnology position peaked at $22.3K in Q1 2025.
6 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.